A Study of Oral Ibogaine in Opioid Withdrawal

Clinical trial NCT05029401 · COMPLETED

Trial details

NCT number: NCT05029401
Sponsor: atai Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Opiate Withdrawal Syndrome

Start date: 2021-04-01
Primary completion: 2024-01-16
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.